Key Contacts
-
Michael F. DeFranco
Partner- Chicago
+ 1 312 861 8230 Email -
Richard G. Blunt
Partner- London
+ 44 20 7919 1842 Email -
Jannan Crozier
Partner- London
+ 44 20 7919 1195 Email -
Matthew Dening
Partner- London
+ 44 20 7919 1818 Email -
Adam B. Farlow
Partner- London
+ 44 20 7919 1514 Email -
Juan Bernardo (JB) García
Partner- Monterrey
+ 52 81 8399 1344 Email -
Karen Guch
Partner- London
+ 44 20 7919 1757 Email -
José Antonio Morán
Partner- Chicago
+ 1 312 861 2829 Email
Latest Thinking

Healthtech and Biotech M&A
The healthcare tech and biotech industries shifted fundamentally during the pandemic. Enthusiasm for dealmaking continues to be a growth area.

Tech M&A Outlook
After a pullback in tech M&A in 2022, and with IPO markets sluggish, dealmakers expect an uptick in M&A activity in 2023.

Cross-Border Dealmaking
The M&A landscape has shifted this year to take account of more strategic concerns. Companies are focused on supply chain disruption, inflation and geopolitical unrest, creating interesting opportunities for buyers.

SPACs in Healthtech
While SPACs offer opportunities for healthtech companies, the road to a de-SPAC process can be complex and perilous.

Digital Assets M&A
How do tech acquisitions differ from other deals? How do you choose your targets? And what are the guests’ biggest tips?